资源描述：
《系统性硬化病中医药治疗进展》由会员上传分享，免费在线阅读，更多相关内容在行业资料-天天文库。
1、系统性硬化病中医药治疗进展【摘要】目的：通过中医理论研究及临床实践操作综合论述系统性硬化病（SSc）的病因病机、中医辨证分型及证型的客观化研究、中医药治疗等方面。着重介绍系统性硬化病的常规中医中药辨证分型、分期治疗及其它经验治疗。这也是目前中医药治疗该病的一个特色和亮点，值得进一步研究和探讨。硬皮病属中医“皮痹”范畴，该病多为本虚标实之证，其病机多认为是脾肾阳虚，气血瘀滞，在治疗上多以补脾益肾、活血化瘀为主。巢元方曰：“风湿痹状，或皮肤顽厚，或肌肉疼痛，由血气虚则受风湿而成此病，日久不愈入经络，搏于阳经，亦变全身手足不遂”。其病机可以
2、概括为气血不足，外感寒湿风邪，致使寒凝肌腠，日久耗伤精血，脏腑虚损，气血瘀滞，实质为本虚标实之证。结果：强调在硬皮病的临证治疗中，不能拘泥于常规分期、分型治疗，应灵活应变，辨证论治，内服结合外治法，全面治疗硬皮病。Objective:throughthetheoreticalresearchandclinicalpracticeoftraditionalChinesemedicinecomprehensivetreatmentofsystemicsclerosis(SSc)ofetiologyandpathogenesis,TCMsy
3、ndromedifferentiationtypeandthetypeofobjectiveresearchandtreatmentoftraditionalChinesemedicine,etc.IntroducesthesystemicsclerosisofconventionaltreatmentoftraditionalChinesemedicineandexperience,andothertreatment.ThisisthetraditionalChinesemedicineintreatmentofthedisease
4、acharacteristicandbrightspot,deservesfurtherresearchanddiscussion.Sclerodermabelongto"bi"categoryoftraditionalChinesemedicine,thisdiseaseformoreofthisvirtualtheactualcard,itspathogenesisismorespleenkidneyYangdeficiency,bloodstasis,morethanonthetreatmentisgivenpriorityto
5、withtonifyingspleenkidneyandpromotingbloodcirculationtoremovebloodstasis.chaoyuanfangsaid:"rheumatismbi,ordensethickskin,andmusclepain,iscomposedbyrheumatismdisease,bloodgasvirtualtimenotintothechannelsandcollaterals,inYangmeridians,alsobecomethebodyfoundinthebrotherhoo
6、dof".Itspathogenesiscanbesummarizedaslackofqiandblood,exogenouswindcolddampnessevil,causehaemorrheologicalnaturemuscleCou,timeconsumedJingXie,visceraisdeficient,qiandbloodstasis,theproofoftheessenceforthisvirtualtoreal.Results:thestressedintheclinicaltreatmentofsclerode
7、rma,notconstrainedintheconventionalstage,partingtreatment,shouldbeflexible,syndromedifferentiationandtreatment,theinternalandexternaltreatmentcombinedwithcomprehensivetreatmentofscleroderma.【关键词】系统性硬化病，中医药治疗，综述【正文】系统性硬化病（SSc）【1】，又称硬皮病(SCL)、进行性系统性硬化，是一种原因不明，临床上以局限性或弥漫性皮肤
8、及内脏器官结缔组织纤维化，硬化及萎缩为特点的结缔组织疾病。临床分为二大类型：局限性硬皮病和系统性硬皮病（SS）。系统性硬皮病又分两亚型：肢端硬皮病和弥漫性硬皮病。本病呈世界性分布。患病率50~300/100万人口，发病率
